Marwood Group supports healthcare providers such as hospitals, physician groups, laboratories, and care delivery organizations with market intelligence, reimbursement analysis, and strategic advisory services. The firm helps providers navigate regulatory changes, optimize financial performance, and evaluate growth opportunities. Its expertise enables healthcare organizations to make informed operational and investment decisions.

Marwood serves pharmaceutical, biotechnology, and life sciences organizations with regulatory, reimbursement, and commercialization intelligence. The company helps clients understand market access challenges, healthcare policy impacts, and emerging industry trends. Its expertise supports product development, investment decisions, and long-term growth strategies.

Proprietary claims-based data analytics covering nearly 12 billion provider and payor claims to deliver actionable insights on volume, utilization, reimbursement, and payor dynamics. Used proprietary claims data to support a national dermatology provider's contracting and growth strategy across 17 states, incorporating feedback from 66 plans. Capabilities include advanced claims data analysis, provider and payor utilization insights, reimbursement pattern analysis, and actionable business intelligence to support contracting strategy, growth planning, and competitive positioning in healthcare markets.

Assessment and advisory on clinical quality management, regulatory compliance, and quality assurance across healthcare provider and life sciences organizations. Capabilities include compliance and quality assessment for healthcare providers and life sciences organizations, clinical and real-world evidence assessment, and regulatory compliance advisory. Demonstrated through transaction support diligence on clinical quality and compliance matters for healthcare investors evaluating provider and life sciences company acquisitions.

Strategic alternatives evaluation and transaction execution for healthcare companies through Marwood Group LLC, a FINRA-registered broker-dealer and state-registered investment adviser. Team comprises veterans of major Wall Street investment banking firms with deep expertise in healthcare transactions and strategic advisory. Capabilities include corporate finance advisory, strategic transaction evaluation, buy-side and sell-side M&A advisory, and transaction execution support for healthcare companies evaluating strategic alternatives and pursuing acquisitions or divestitures.

International healthcare market intelligence and advisory providing global perspectives on policy, reimbursement, and market dynamics. Dedicated focus area providing global services across regulatory, reimbursement, and market entry strategy. Capabilities include international healthcare policy and regulatory analysis, global reimbursement strategy advisory, market entry strategy for international expansion, and global healthcare market intelligence to support strategic planning and investment decisions across geographies.

Achieving success in healthcare requires a deep understanding of the influence government policy and politics has on reimbursement and regulation. Advisory on the influence of government policy and politics on reimbursement and regulation across healthcare sub-sectors, with specific expertise in assessing regulatory trends and policy outlook for transaction due diligence and strategic planning. Capabilities include policy analysis across healthcare sub-sectors, regulatory monitoring to track policy changes affecting reimbursement models, and economics advisory on how policy shifts impact healthcare markets and investment decisions.

Strategic advisory to investors, developers, manufacturers, and contract services organizations across pharmaceuticals, biotech, MedTech, and HealthTech on go-to-market, regulatory, reimbursement, and commercial strategy. Services span developers and manufacturers (including gene therapy, AI-based pathology, wearable MedTech), PE/venture/hedge fund investors, and contract services organizations. Capabilities include go-to-market strategy development, regulatory strategy and compliance advisory, reimbursement strategy and market access planning, commercial strategy, market sizing, competitive landscaping, pricing analysis, and transaction diligence including clinical and real-world evidence assessment for life sciences and healthcare technology investments.

In-depth market sizing, competitive landscaping, and strategic market analysis for healthcare investors and corporates. Capabilities encompass comprehensive market assessment including market size quantification, clinical and drug pipeline analysis, competitive positioning, and pricing dynamics across healthcare segments. Demonstrated through transaction support case studies assessing market studies for clinical trial site management organizations and national provider networks, incorporating analysis of market size, competitive landscapes, and clinical/drug pipelines to inform investment and M&A decisions.

Operational and financial performance optimization for healthcare providers including revenue enhancement, cost reduction, and operational transformation. Marwood transformed a national laboratory services provider's revenue cycle over a 13-month engagement, realizing significant improvements in RCM capabilities, billing practices, and financial processes. Capabilities include revenue cycle optimization, cost reduction program design and execution, and operational performance improvement targeting healthcare provider profitability and operational efficiency.

Marwood delivers healthcare policy, regulatory, and market intelligence through curated research publications. These insights keep stakeholders informed about emerging trends and industry developments. The service supports strategic planning and investment decisions.